跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 730 条关于
“SATT AxLR”
全部
730
临床试验
540
药物
88
机构
20
资讯
82
去年
SPIMA Therapeutics Launches with Exclusive License for Myddosome Inhibitor SPM001
去年
SpikImm Secures Worldwide License for Anti-BK Virus Monoclonal Antibodies to Protect Transplant Patients
7个月前
Kahimmune Therapeutics Secures Exclusive License for Dark Genome Cancer Vaccine Platform
去年
Find Therapeutics Doses First Subject in Phase I Trial of FTX-101 for Chronic Optic Neuropathy
去年
AdipoPharma Secures Funding for Phase 1 Clinical Trials of Novel Type 2 Diabetes Drug
去年
EMA Grants First-Ever Orphan Drug Designation for Radiation Maculopathy Treatment
去年
Massalia Therapeutics Launches with Seed Funding to Target Fibrosis-Neoplasm-Neovascularization Interface
去年
InBrain Pharma Secures €1.8 Million to Industrialize Anaerobic Dopamine Production for Advanced Parkinson's Disease
2个月前
MoatRx Launches AXLRx AI Pharma Intelligence Platform for Commercial Consulting
去年
Axle Health Raises $10M Series A to Scale AI-Powered Home Healthcare Platform
第 1 页,共 9 页
上一页
下一页